19 July 2017 EMA/574447/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: isotretinoin (oral formulations)

Procedure no.: PSUSA/00010488/201611

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number A-CNOTREN 10mg καψάκια A-cnotren FLEXRESAN 10 mg cápsulas blandas

DK/H/0889/001

45/16-01-2012

PHARMATHEN HELLAS S.A.

GR

not available not available

45047/10/18-04-2012 66.160

GR ES

FLEXRESAN 20 mg cápsulas blandas

not available

66.159

Tretoskin, 10 mg, kapsułki miękkie Tretoskin, 10 mg, kapsułki miękkie Tretoskin, 20 mg, kapsułki miękkie Tretoskin, 20 mg, kapsułki miękkie Roaccutane 10 mg zachte capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg zachte capsules Roaccutane 20 mg Weichkapseln Roaccutan 10 mg mjuka kapslar Roaccutan 20 mg mjuka kapslar Roaccutane 10 mg soft capsules Roaccutane 20 mg soft capsules Roaccutane 10 mg Soft Capsules

not available

12054

PHARMATHEN HELLAS S.A. ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A VITAMA S.A.

not available

12054

VITAMA S.A.

PL

not available

12053

VITAMA S.A.

PL

not available

12053

VITAMA S.A.

PL

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/0666/001

9220

ROCHE OY

FI

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/0666/001

PL 00031/0617

ROCHE PRODUCTS LTD

UK

UK/H/0666/002

PL 00031/0160

ROCHE PRODUCTS LTD

UK

UK/H/0666/001

PA50/53/5

ROCHE PRODUCTS LTD

IE

List of nationally authorised medicinal products EMA/574447/2017

ES PL

Page 2/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Roaccutane 20 mg Soft Capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg Weichkapseln Roaccutane 10 mg mehke kapsule Roaccutane 10 mg mehke kapsule Roaccutane 20 mg mehke kapsule Roaccutane 20 mg mehke kapsule Roaccutane 10 mg mehke kapsule Roaccutane 20 mg mehke kapsule Roaccutane 20 mg, pehmekapslid Roaccutane 10 mg, pehmekapslid Roaccutane 10 mg capsules molles Roaccutane 20 mg capsules molles Roaccutan 10 mg pehmeät kapselit Roaccutan 20 mg pehmeät kapselit Roaccutane 20 mg capsules molles Roaccutane 10 mg capsules molles

UK/H/0666/002

PA50/53/4

ROCHE PRODUCTS LTD

IE

UK-H-666

0178/10010651

N.V. ROCHE S.A.

LU

UK-H-666

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

H/96/01368/002

SI

UK/H/0666/001

H/96/01368/003

UK/H/0666/002

H/96/01368/007

UK/H/0666/002

H/96/01368/008

UK/H/0666/001

H/96/01368/004

UK/H/0666/002

H/96/01368/006

NL/H/666/002

404002

ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE EESTI OÜ

NL/H/666/001

052294

ROCHE EESTI OÜ

EE

UK/H/0666/001

0178/10010651

N.V. ROCHE S.A.

LU

UK/H/0666/002

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

9220

ROCHE OY

FI

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

List of nationally authorised medicinal products EMA/574447/2017

SI SI SI SI SI EE

Page 3/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Roaccutane 10 mg capsule moi Roaccutan 10 mg lágy kapszula Roaccutan 20 mg lágy kapszula Roaccutane 20 mg mäkké kapsuly Roaccutane 10 mg mäkké kapsuly Roaccutane 10 mg mehke kapsule Roaccutane 20 mg mehke kapsule Роакутан 20 mg капсули, меки Roaccutane 10 mg meke kapsule Roaccutane 10 mg minkštosios kapsulės Roaccutane 10 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg mīkstās kapsulas Roaccutane 10 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg mīkstās kapsulas

not available

7661/2015/01

ROCHE ROMANIA SRL

RO

UK/H/0666/001

OGYI-T-1278/01

HU

UK/H/0666/002

OGYI-T-1278/02

UK/H/0666/002

46/0361/05-S

ROCHE (MAGYARORSZÁG) KFT ROCHE (MAGYARORSZÁG) KFT ROCHE SLOVENSKO S.R.O.

UK/H/0666/001

46/0360/05-S

ROCHE SLOVENSKO S.R.O.

SK

UK/H/666/001

H/96/01368/001

SI

UK/H/666/002

H/96/01368/005

not available

20030084

ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE BULGARIA EOOD

not available

HR-H-462694255

ROCHE D.O.O.

HR

UK/H/0666/001

LT/1/05/0406/003

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

LT/1/05/0406/001

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/006

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

05-0517

ROCHE LATVIJA SIA

LV

UK/H/0666/001

LT/1/05/0406/004

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/008

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/007

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

05-0518

ROCHE LATVIJA SIA

LV

List of nationally authorised medicinal products EMA/574447/2017

HU SK

SI BG

Page 4/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg minkštosios kapsulės CONTRACNE 5 mg, capsule molle CONTRACNE 5 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 20 mg, capsule molle CONTRACNE 20 mg, capsule molle CONTRACNE 20 mg, capsule molle CONTRACNE 40 mg, capsule molle CONTRACNE 40 mg, capsule molle Isdiben 10 mg capsule molli Isdiben 10 mg capsule molli Isdiben 10 mg capsule molli Isotretinoin 10 mg Soft Capsules Isotretinoin 20 mg Soft Capsules

UK/H/0666/002

LT/1/05/0406/005

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

LT/1/05/0406/002

UAB "ROCHE LIETUVA"

LT

not available

34009 382 601 9 9

BAILLEUL

FR

not available

34009 382 602 5 0

BAILLEUL

FR

not available

358 120-4

BAILLEUL

FR

not available

358 121-0

BAILLEUL

FR

not available

358 122-7

BAILLEUL

FR

not available

358 116-7

BAILLEUL

FR

not available

358 117-3

BAILLEUL

FR

not available

358 119-6

BAILLEUL

FR

not available

367 884-3

BAILLEUL

FR

not available

367 888-9

BAILLEUL

FR

UK/H/3577/002

041853045

LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA LABORATOIRES SA ISDIN S.R.L.

UK/H/3577/002

041853058

ISDIN S.R.L.

IT

UK/H/3577/002

041853060

ISDIN S.R.L.

IT

UK/H/3577/002

PL 04569/1344

GENERICS [UK] LIMITED

UK

UK/H/3577/003

PL 04569/1345

GENERICS [UK] LIMITED

UK

List of nationally authorised medicinal products EMA/574447/2017

IT

Page 5/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoin 40 mg Soft Capsules Isotretinoin 5 mg Soft Capsules Isdiben 40 mg cápsulas blandas Isdiben 5 mg capsule molli Isdiben 5 mg capsule molli Isdiben 5 mg capsule molli Isdiben 20 mg capsule molli Isdiben 20 mg capsule molli Isdiben 20 mg capsule molli Isdiben 40 mg capsule molli Isdiben 40 mg capsule molli Isdiben 40 mg capsule molli Isotretinoína Orotrex 10 mg cápsulas moles

UK/H/3577/004

PL 04569/1346

GENERICS [UK] LIMITED

UK

UK/H/3577/001

PL 04569/1343

GENERICS [UK] LIMITED

UK

UK/H/3577/004

76.045

ISDIN, S.A.

ES

UK/H/3577/001

041853019

ISDIN S.R.L.

IT

UK/H/3577/001

041853021

ISDIN S.R.L.

IT

UK/H/3577/001

041853033

ISDIN S.R.L.

IT

UK/H/3577/003

041853072

ISDIN S.R.L.

IT

UK/H/3577/003

041853084

ISDIN S.R.L.

IT

UK/H/3577/003

041853096

ISDIN S.R.L.

IT

UK/H/3577/004

041853108

ISDIN S.R.L.

IT

UK/H/3577/004

041853110

ISDIN S.R.L.

IT

UK/H/3577/004

041853122

ISDIN S.R.L.

IT

not available

5174693

PT

Isotretinoína Orotrex 10 mg cápsulas moles

not available

4882494

Isotretinoína Orotrex 10 mg cápsulas moles

not available

5174792

LABORATÓRIO MEDINFAR PRODUTOS FARMACÊUTICOS, S.A. LABORATÓRIO MEDINFAR PRODUTOS FARMACÊUTICOS, S.A. LABORATÓRIO MEDINFAR PRODUTOS FARMACÊUTICOS, S.A.

List of nationally authorised medicinal products EMA/574447/2017

PT PT

Page 6/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised PT

number Isotretinoína Orotrex 20 mg cápsulas moles

not available

4882593

Isotretinoína Orotrex 20 mg cápsulas moles

not available

5174891

Dercutane 20 mg cápsulas blandas Sotret 10 mg capsule moi Sotret 20 mg capsule moi Sotret 20 mg lágy kapszula Sotret 20 mg lágy kapszula Sotret 20 mg lágy kapszula Sotret 10 mg lágy kapszula Sotret 20 mg lágy kapszula Sotret 10 mg lágy kapszula Sotret 10 mg lágy kapszula Sotret 10 mg lágy kapszula Isotretinoin Orifarm 10 mg kapslar, mjuka Isotretinoin Orifarm 20 mg kapslar, mjuka Isotretinoin ”Orifarm”, bløde kapsler

not available

65.334

not available

6765/2014/01

LABORATÓRIO MEDINFAR PRODUTOS FARMACÊUTICOS, S.A. LABORATÓRIO MEDINFAR PRODUTOS FARMACÊUTICOS, S.A. INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. TERAPIA S.A.

not available

6766/2014/01

TERAPIA S.A.

RO

not available

OGYI-T-8989/07

TERAPIA S.A.

HU

not available

OGYI-T-8989/06

TERAPIA S.A.

HU

not available

OGYI-T-8989/05

TERAPIA S.A.

HU

not available

OGYI-T-8989/01

TERAPIA S.A.

HU

not available

OGYI-T-8989/08

TERAPIA S.A.

HU

not available

OGYI-T-8989/02

TERAPIA S.A.

HU

not available

OGYI-T-8989/04

TERAPIA S.A.

HU

not available

OGYI-T-8989/03

TERAPIA S.A.

HU

DK/H/1060/001

47763

ORIFARM GENERICS A/S

SE

DK/H/1060/002

47764

ORIFARM GENERICS A/S

SE

DK/H/1060/001

34484

ORIFARM GENERICS A/S

DK

List of nationally authorised medicinal products EMA/574447/2017

PT ES RO

Page 7/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoin ”Orifarm”, bløde kapsler Isotretinoin Orifarm 10 mg kapsler, myke Isotretinoin Orifarm 20 mg kapsler, myke Isotretinoin Orifarm 20 mg kapseli, pehmeä IsoGalen® 20 mg Weichkapseln IsoGalen® 10 mg Weichkapseln Isotretinoína Generis 10 mg Cápsulas moles Isotretinoína Generis 10 mg Cápsulas moles Isotretinoína Generis 10 mg Cápsulas moles Isotretinoína Generis 10 mg Cápsulas moles Isotretinoína Generis 20 mg Cápsulas moles Isotretinoína Generis 20 mg Cápsulas moles Isotretinoína Generis 20 mg Cápsulas moles Isotretinoína Generis 20 mg Cápsulas moles Isoderm 10 mg Isoderm 20 mg Isoderm, 10 mg, kapsułki, miękkie Isoderm, 20 mg, kapsulki, miekkie

DK/H/1060/002

34485

ORIFARM GENERICS A/S

DK

DK/H/1060/001

07-5310

ORIFARM GENERICS A/S

NO

DK/H/1060/002

07-5311

ORIFARM GENERICS A/S

NO

DK/H/1060/002

24197

ORIFARM GENERICS A/S

FI

DK/H/1060/001

71369.00.00

GALENPHARMA GMBH

DE

DK/H/1060/002

71368.00.00

GALENPHARMA GMBH

DE

not available

5503297

PT

not available

4882296

not available

5161591

not available

5113923

not available

5503396

not available

4882395

not available

5161492

not available

5113931

not available not available not available

48903.00.00 48903.01.00 18136

not available

18137

GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. GENERIS FARMACÊUTICA, S.A. DERMAPHARM AG DERMAPHARM AG SUN-FARM SP. Z.O.O. (KOLBIEL) SUN-FARM SP. Z.O.O. (KOLBIEL)

List of nationally authorised medicinal products EMA/574447/2017

PT PT PT PT PT PT PT DE DE PL PL

Page 8/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Axotret10 mg, kapsułki, miękkie Axotret 20 mg, kapsułki, miękkie Isotretinoïne 20 PCH, capsules 20 mg Roaccutane 10 mg zachte capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg zachte capsules Roaccutane 20 mg Weichkapseln Roaccutan 10 mg mjuka kapslar Roaccutan 20 mg mjuka kapslar Roaccutane 10 mg soft capsules Roaccutane 20 mg soft capsules Roaccutane 10 mg Soft Capsules Roaccutane 20 mg Soft Capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg Weichkapseln Roaccutane 10 mg mehke kapsule Roaccutane 10 mg mehke kapsule

not available

11318

AXXON SP. Z O.O.

PL

not available

11319

AXXON SP. Z O.O.

PL

NL/H/902/002

RVG 27576

PHARMACHEMIE B.V

NL

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/0666/001

9220

ROCHE OY

FI

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/0666/001

PL 00031/0617

ROCHE PRODUCTS LTD

UK

UK/H/0666/002

PL 00031/0160

ROCHE PRODUCTS LTD

UK

UK/H/0666/001

PA50/53/5

ROCHE PRODUCTS LTD

IE

UK/H/0666/002

PA50/53/4

ROCHE PRODUCTS LTD

IE

UK-H-666

0178/10010651

N.V. ROCHE S.A.

LU

UK-H-666

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

H/96/01368/002

SI

UK/H/0666/001

H/96/01368/003

ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O.

List of nationally authorised medicinal products EMA/574447/2017

SI

Page 9/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised SI

number Roaccutane 20 mg mehke kapsule Roaccutane 20 mg mehke kapsule Roaccutane 10 mg mehke kapsule Roaccutane 20 mg mehke kapsule Roaccutane 20 mg, pehmekapslid Roaccutane 10 mg, pehmekapslid Roaccutane 10 mg capsules molles Roaccutane 20 mg capsules molles Roaccutan 10 mg pehmeät kapselit Roaccutan 20 mg pehmeät kapselit Roaccutane 20 mg capsules molles Roaccutane 10 mg capsules molles Roaccutan 10 mg lágy kapszula Roaccutan 20 mg lágy kapszula Roaccutane 20 mg mäkké kapsuly Roaccutane 10 mg mäkké kapsuly Roaccutane 10 mg mehke kapsule

UK/H/0666/002

H/96/01368/007

UK/H/0666/002

H/96/01368/008

UK/H/0666/001

H/96/01368/004

UK/H/0666/002

H/96/01368/006

NL/H/666/002

404002

ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE FARMACEVTSKA DRUŽBA D.O.O. ROCHE EESTI OÜ

NL/H/666/001

052294

ROCHE EESTI OÜ

EE

UK/H/0666/001

0178/10010651

N.V. ROCHE S.A.

LU

UK/H/0666/002

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

9220

ROCHE OY

FI

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/0666/001

OGYI-T-1278/01

HU

UK/H/0666/002

OGYI-T-1278/02

UK/H/0666/002

46/0361/05-S

ROCHE (MAGYARORSZÁG) KFT ROCHE (MAGYARORSZÁG) KFT ROCHE SLOVENSKO S.R.O.

UK/H/0666/001

46/0360/05-S

ROCHE SLOVENSKO S.R.O.

SK

UK/H/666/001

H/96/01368/001

ROCHE FARMACEVTSKA DRUŽBA D.O.O.

SI

List of nationally authorised medicinal products EMA/574447/2017

SI SI SI EE

HU SK

Page 10/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised SI

number Roaccutane 20 mg mehke kapsule Roaccutane 10 mg minkštosios kapsulės Roaccutane 10 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg mīkstās kapsulas Roaccutane 10 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg mīkstās kapsulas Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg minkštosios kapsulės Isotretinoïne EG 10 mg capsules molles Isotretinoïne EG 10 mg zachte capsules Isotretinoïne EG 10 mg Weichkapseln Isotrétinoïne EG 10 mg capsules molles Rotaxin 10mg soft gelatin capsules Rotaxin 20mg soft gelatin capsules

UK/H/666/002

H/96/01368/005

UK/H/0666/001

LT/1/05/0406/003

ROCHE FARMACEVTSKA DRUŽBA D.O.O. UAB "ROCHE LIETUVA"

UK/H/0666/001

LT/1/05/0406/001

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/006

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

05-0517

ROCHE LATVIJA SIA

LV

UK/H/0666/001

LT/1/05/0406/004

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/008

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/007

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

05-0518

ROCHE LATVIJA SIA

LV

UK/H/0666/002

LT/1/05/0406/005

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

LT/1/05/0406/002

UAB "ROCHE LIETUVA"

LT

BE/H/0193/001

0019/05060039

EUROGENERICS SA

LU

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

not available

21122

HADJICONSTANTINOU BROS

CY

not available

21123

HADJICONSTANTINOU BROS

CY

List of nationally authorised medicinal products EMA/574447/2017

LT

Page 11/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number MAYESTA 10 mg cápsulas blandas MAYESTA 20 mg cápsulas blandas ACTAVEN, 10 MG, KAPSULKI, MIEKKIE ACTAVEN, 20 MG, KAPSUŁKI, MIĘKKIE Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula ACNENOR, BLØDE KAPSLER Inerta 10 mg lágy kapszula ISOTRETINOIN ACTAVIS 10 MG KAPSLAR, MJUKA

not available

69.571

BAMA-GEVE, S.L.U.

ES

not available

69.572

BAMA-GEVE, S.L.U.

ES

DK/H/2242/001

21632

ACTAVIS GROUP PTC EHF.

PL

DK/H/2242/002

21633

ACTAVIS GROUP PTC EHF.

PL

DK/H/2242/001

OGYI-T-22560/02

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/03

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/04

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/05

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/11

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/07

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/08

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/09

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/10

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/12

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

51479

ACTAVIS GROUP PTC EHF.

DK

DK/H/2242/001

OGYI-T-22560/01

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

48555

ACTAVIS GROUP PTC EHF.

SE

List of nationally authorised medicinal products EMA/574447/2017

Page 12/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number ISOTRETINOIN ACTAVIS 10 MG MÄKKÉ KAPSULY ACNENOR, BLØDE KAPSLER Inerta 20 mg lágy kapszula ISOTRETINOIN ACTAVIS 20 MG KAPSLAR, MJUKA ISOTRETINOIN ACTAVIS 20 MG MÄKKÉ KAPSULY ISOSUPRA LIDOSE 8 mg, gélules ISOSUPRA LIDOSE 8 mg, capsules, hard Isosupra Lidose 8 mg Hartkapsel ISOSUPRA LIDOSE 16 mg, gélules Isosupra Lidose 16 mg, capsules, hard Isosupra Lidose 16 mg Hartkapsel ISOTRETINOIN ”ACTAVIS”, BLØDE KAPSLER 40 MG ISOTRETINOIN ACTAVIS 40 MG, KAPSELI, PEHMEÄ Ciscutan 40 mg – Kapseln Aknenormin 20 mg Weichkapseln Aknenormin 20 mg měkké tobolky

DK/H/2242/001

46/0418/13-S

ACTAVIS GROUP PTC EHF.

SK

DK/H/2242/002

51480

ACTAVIS GROUP PTC EHF.

DK

DK/H/2242/002

OGYI-T-22560/06-10

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

48556

ACTAVIS GROUP PTC EHF.

SE

DK/H/2242/002

46/0419/13-S

ACTAVIS GROUP PTC EHF.

SK

not available

BE266533

LABORATOIRES SMB S.A.

BE

not available

BE266533

LABORATOIRES SMB S.A.

BE

not available

BE 266533

LABORATOIRES SMB S.A.

BE

not available

BE266542

LABORATOIRES SMB S.A.

BE

not available

BE266542

LABORATOIRES SMB S.A.

BE

not available

BE 266542

LABORATOIRES SMB S.A.

BE

DK/H/1747/001

37461

ACTAVIS GROUP PTC EHF.

DK

DK/H/1747/001

27968

ACTAVIS GROUP PTC EHF.

FI

not available

1-27652

PELPHARMA HANDELS GMBH

AT

DE/H/1702/002/MR

55003.01.00

ALMIRALL HERMAL GMBH

DE

DE/H/1702/002/MR

46/139/05-C

ALMIRALL HERMAL GMBH

CZ

List of nationally authorised medicinal products EMA/574447/2017

Page 13/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Aknenormin 20 mg lágy kapszula Aknenormin 20 Mäkké kapsuly Aknenormin, 20 mg, kapsułki miękkie Aknenormin 10 mg Weichkapseln Aknenormin 10 mg měkké tobolky Aknenormin 10 mg lágy kapszula Aknenormin, 10 mg, kapsulki miękkie Aknenormin 10 Mäkké kapsuly Isotretinoin Actavis 40 mg mjúk hylki AISOSKIN 10 mg capsule molli AISOSKIN 20 mg capsule molli Dercutane 10 mg cápsulas blandas Izotek 10 mg, kapsułki, miękkie Izotek 20 mg, kapsułki, miękkie CURACNÉ 10 mg, capsule molle ISOCURAL 10 mg, zachte capsules ISOACNÉ 10 mg cápsulas blandas

DE/H/1702/002/MR

OGYI-T-10171/01

ALMIRALL HERMAL GMBH

HU

DE/H/1702/002/MR

46/0129/05-S

ALMIRALL HERMAL GMBH

SK

DE/H/1702/002/MR

11426

ALMIRALL HERMAL GMBH

PL

DE/H/1702/001/MR

55003.00.00

ALMIRALL HERMAL GMBH

DE

DE/H/1702/001/MR

46/138/05-C

ALMIRALL HERMAL GMBH

CZ

DE/H/1702/001/MR

OGYI-T-10170/01

ALMIRALL HERMAL GMBH

HU

DE/H/1702/001/MR

11427

ALMIRALL HERMAL GMBH

PL

DE/H/1702/001/MR

46/0130/05-S

ALMIRALL HERMAL GMBH

SK

not available

IS/1/16/035/02

ACTAVIS GROUP PTC EHF.

IS

not available

035258019

FIDIA FARMACEUTICI S.P.A

IT

not available

035258021

FIDIA FARMACEUTICI S.P.A

IT

not available

65.333

ES

DK/H/0889/001

12350

DK/H/0889/002

12349

FR/H/0250/002

358 129 1

FR/H/0250/002

BE280411

INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. PHARMASWISS ČESKÁ REPUBLIKA S.R.O. PHARMASWISS ČESKÁ REPUBLIKA S.R.O. PIERRE FABRE DERMATOLOGIE PIERRE FABRE BENELUX

FR/H/0250/002

67.570

PIERRE FABRE IBERICA / SPAIN

ES

List of nationally authorised medicinal products EMA/574447/2017

PL PL FR BE

Page 14/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number ISORIAC 10 mg, capsule molli CURACNÉ Gé 10 mg, capsule molle Curacne 10 mg Kapsulki miekkie Isotretinoína Pierre Fabre 10 mg cápsulas moles CURACNÉ 20 mg, capsule molle ISOCURAL 20 mg, capsules molles ISOACNÉ 20 mg cápsulas blandas ISORIAC 20 mg, capsule molli CURACNÉ Gé 20 mg, capsule molle Curacne 20 mg Kapsulki miekkie Isotretinoína Pierre Fabre 20 mg cápsulas moles CURACNÉ 40 mg, capsule molle ISOCURAL 40 mg, capsules molles ISOACNÉ 40 mg cápsulas blandas CURACNÉ 40 mg, capsule molle Curacne 40 mg Kapsułki miękkie CURACNÉ 5 mg, capsule molle

FR/H/0250/002

037551025

PIERRE FABRE ITALIA S.P.A.

IT

FR/H/0250/002

1128/09020250

LU

FR/H/0250/002

11919

FR/H/0250/002

5732482

PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PFDC / PORTUGAL

FR/H/0250/003

358 115 0

FR

FR/H/0250/003

BE280427

PIERRE FABRE DERMATOLOGIE PIERRE FABRE BENELUX

FR/H/0250/003

67.571

ES

FR/H/0250/003

037551076

PIERRE FABRE IBERICA / SPAIN PIERRE FABRE ITALIA S.P.A.

FR/H/0250/003

1128/09020249

LU

FR/H/0250/003

11918

FR/H/0250/003

5732987

PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PFDC / PORTUGAL

FR/H/0250/004

367 603.4

FR

FR/H/0250/004

BE 334047

PIERRE FABRE DERMATOLOGIE PIERRE FABRE BENELUX

FR/H/0250/004

69.927

ES

FR/H/0250/004

1128/08010002

FR/H/0250/004

14709

FR/H/0250/001

358 123 3

PIERRE FABRE IBERICA / SPAIN PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE

List of nationally authorised medicinal products EMA/574447/2017

PL PT

BE

IT

PL PT

BE

LU PL FR

Page 15/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number ISOCURAL 5 mg, capsules molles ISOACNÉ 5 mg cápsulas blandas CURACNÉ Gé 5 mg, capsule molle CURACNÉ 40 mg|mäkké kapsuly Isotretinoína Pierre Fabre 5 mg, cápsulas moles ISOCURAL 10 mg, capsules molles ISOCURAL 20 mg, zachte capsules ISOCURAL 40 mg, zachte capsules ISOCURAL 5 mg, zachte capsules CURACNÉ 10 mg, capsule molle CURACNÉ 10 mg, capsule molle CURACNÉ 10 mg, capsule molle CURACNÉ 10 mg, capsule molle CURACNÉ 20 mg, capsule molle CURACNÉ 20 mg, capsule molle CURACNÉ 20 mg, capsule molle CURACNÉ 20 mg, capsule molle

FR/H/0250/001

BE280402

PIERRE FABRE BENELUX

BE

FR/H/0250/001

67.464

ES

FR/H/0250/001

1128/09020251

FR/H/0250/001

11920

FR/H/0250/001

5731989

PIERRE FABRE IBERICA / SPAIN PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PFDC / PORTUGAL

FR/H/0250/002

BE280411

PIERRE FABRE BENELUX

BE

FR/H/0250/003

BE280427

PIERRE FABRE BENELUX

BE

FR/H/0250/004

BE334047

PIERRE FABRE BENELUX

BE

FR/H/0250/001

BE280402

PIERRE FABRE BENELUX

BE

FR/H/0250/002

34009 358 131 6 9

FR

FR/H/0250/002

34009 358 134 5 9

FR/H/0250/002

34009 358 132 2 0

FR/H/0250/002

34009 358 133 9 8

FR/H/0250/003

34009 358 135 1 0

FR/H/0250/003

34009 358 136 8 8

FR/H/0250/003

34009 358 157 5 0

FR/H/0250/003

34009 358 158 1 1

PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE

List of nationally authorised medicinal products EMA/574447/2017

LU PL PT

FR FR FR FR FR FR FR

Page 16/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised FR

number CURACNÉ 5 mg, capsule molle CURACNÉ 5 mg, capsule molle CURACNÉ 5 mg, capsule molle CURACNÉ 5 mg, capsule molle Isotretinoína Pierre Fabre 10 mg cápsulas moles Isotretinoína Pierre Fabre 10 mg cápsulas moles Isotretinoína Pierre Fabre 10 mg cápsulas moles Isotretinoína Pierre Fabre 10 mg cápsulas moles Isotretinoína Pierre Fabre 20 mg cápsulas moles Isotretinoína Pierre Fabre 20 mg cápsulas moles Isotretinoína Pierre Fabre 20 mg cápsulas moles Isotretinoína Pierre Fabre 20 mg cápsulas moles Isotretinoína Pierre Fabre 5 mg, cápsulas moles Isotretinoína Pierre Fabre 5 mg, cápsulas moles Isotretinoína Pierre Fabre 5 mg, cápsulas moles Isotretinoína Pierre Fabre 5 mg, cápsulas moles CURACNÉ 10 mg měkká tobolka

FR/H/0250/001

34009 358 125 6 8

FR/H/0250/001

34009 358 126 2 9

FR/H/0250/001

34009 358 127 9 7

FR/H/0250/001

34009 358 128 5 8

FR/H/0250/002

5732581

PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PFDC / PORTUGAL

FR/H/0250/002

5732680

PFDC / PORTUGAL

PT

FR/H/0250/002

5732789

PFDC / PORTUGAL

PT

FR/H/0250/002

5732888

PFDC / PORTUGAL

PT

FR/H/0250/003

5733084

PFDC / PORTUGAL

PT

FR/H/0250/003

5733183

PFDC / PORTUGAL

PT

FR/H/0250/003

5733282

PFDC / PORTUGAL

PT

FR/H/0250/003

5733381

PFDC / PORTUGAL

PT

FR/H/0250/001

5732086

PFDC / PORTUGAL

PT

FR/H/0250/001

5732185

PFDC / PORTUGAL

PT

FR/H/0250/001

5732284

PFDC / PORTUGAL

PT

FR/H/0250/001

5732383

PFDC / PORTUGAL

PT

FR/H/0250/002

46/056/06-C

PIERRE FABRE DERMATOLOGIE

CZ

List of nationally authorised medicinal products EMA/574447/2017

FR FR FR PT

Page 17/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised CZ

number CURACNÉ 20 mg měkká tobolka CURACNÉ 40 mg, měkká tobolka CURACNÉ 40 mg mäkké kapsuly Isdiben 10 mg cápsulas blandas Isdiben 20 mg cápsulas blandas Isotretinoïne Mylan 10 mg, zachte capsules Isotretinoïne Mylan 20 mg, zachte capsules Isotretinoin 10 mg Soft Capsules Isotretinoin 20 mg Soft Capsules Isotretinoin 5 mg Soft Capsules Tretin 10mg , καψάκια μαλακά Tretin 20mg, καψάκια μαλακά Dercutane 30 mg cápsulas blandas Isotretinoin PUREN 10 mg Weichkapseln Isotretinoin PUREN 20 mg Weichkapseln Isotretinoïne Aurobindo 10 mg, capsules Isotretinoïne Aurobindo 20 mg, capsules

FR/H/0250/003

46/054/06-C

FR/H/0250/004

46/095/08-C

FR/H/0250/004

46/0119/08-S

UK/H/0504/002

66.121

PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE PIERRE FABRE DERMATOLOGIE ISDIN, S.A.

UK/H/0504/003

66.122

ISDIN, S.A.

ES

UK/H/0504/002

RVG 27573

MYLAN B.V.

NL

UK/H/0504/003

RVG 27574

MYLAN B.V.

NL

UK/H/0504/002

PL 04569/0725

GENERICS [UK] LIMITED

UK

UK/H/0504/003

PL 04569/0724

GENERICS [UK] LIMITED

UK

UK/H/0504/001

PL 04569/0726

GENERICS [UK] LIMITED

UK

not available

66320/14/07-01-2015

GR

not available

85176/14/07-01-2015

not available

78.326

DK/H/0297/001

54253.00.00

DK/H/0297/002

54253.01.00

DK/H/0297/001

RVG 27577

TARGET PHARMA SINGLE MEMBER PRIVATE LTD TARGET PHARMA SINGLE MEMBER PRIVATE LTD INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. PUREN PHARMA GMBH & CO. KG PUREN PHARMA GMBH & CO. KG AUROBINDO PHARMA B.V.

DK/H/0297/002

RVG 27578

AUROBINDO PHARMA B.V.

NL

List of nationally authorised medicinal products EMA/574447/2017

CZ SK ES

GR ES DE DE NL

Page 18/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised PT

number Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 20 mg Cápsulas moles Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoin “Actavis”, bløde kapsler Isotretinoin “Actavis”, bløde kapsler ISOTRETINOIN ACTAVIS 10 MG, KAPSELI, PEHMEÄ ISOTRETINOIN ACTAVIS 20 MG, KAPSELI, PEHMEÄ

DK/H/0297/001

4057584

DK/H/0297/001

4057683

DK/H/0297/001

4057782

DK/H/0297/001

4057881

DK/H/0297/001

4057980

DK/H/0297/002

4058087

DK/H/0297/002

4058186

DK/H/0297/002

4058285

DK/H/0297/002

4058384

DK/H/0297/002

4058483

DK/H/0297/002

DK/H/0297/002

DK/H/297/01

DK/H/297/01

DK/H/0297/002

31472

AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. AUROVITAS UNIPESSOAL, LDA. ACTAVIS GROUP PTC EHF.

DK/H/0297/001

31471

ACTAVIS GROUP PTC EHF.

DK

DK/H/0297/001

17179

ACTAVIS GROUP PTC EHF.

FI

DK/H/0297/002

17180

ACTAVIS GROUP PTC EHF.

FI

List of nationally authorised medicinal products EMA/574447/2017

PT PT PT PT PT PT PT PT PT PT PT DK

Page 19/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised UK

number Isotretinoin 5 mg capsules Isotretinoin 20mg soft capsules Reticutan 20mg soft capsules Ciscumed 5 mg – Kapseln ACNETRAIT 5 mg, capsule molle ACNETRAIT 10 mg, capsule molle ACNETRAIT 20 mg, capsule molle ACNETRAIT 40 mg, capsule molle Decutan 10 mg hylki, mjúk Decutan 20 mg hylki, mjúk ISOMACNE, BLØDE KAPSLER ISOMACNE, BLØDE KAPSLER Isotretinoin Actavis 40 mg mjúk hylki Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula

AT/H/0164/001/DC

PL 40739/0002

not available

PL 40739/0001

not available

PL 40739/0001

AT/H/0164/001

1-27153

not available

NL 36265

ENNOGEN HEALTHCARE LIMITED ENNOGEN HEALTHCARE LIMITED ENNOGEN HEALTHCARE LIMITED ENNOGEN HEALTHCARE LIMITED ARROW GENERIQUES

not available

NL 26226

ARROW GENERIQUES

FR

not available

NL 26227

ARROW GENERIQUES

FR

not available

NL 36266

ARROW GENERIQUES

FR

DK/H/0368/001

IS/1/02/035/01

ACTAVIS HF.

IS

DK/H/0368/002

IS/1/02/035/02

ACTAVIS HF.

IS

DK/H/0368/002

33137

ACTAVIS GROUP PTC EHF.

DK

DK/H/0368/001

33136

ACTAVIS GROUP PTC EHF.

DK

not available

IS/1/16/035/02

ACTAVIS GROUP PTC EHF.

IS

not available

OGYI-T-20238/05

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/04

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/10

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/06

TEVA MAGYARORSZÁG ZRT

HU

List of nationally authorised medicinal products EMA/574447/2017

UK UK AT FR

Page 20/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Dercutane 5 mg cápsulas blandas Acnemin 10 mg cápsulas blandas Acnemin 20 mg cápsulas blandas Ciscutan 10 mg – Kapseln Ciscutan 20 mg – Kapseln ROCNE ROCNE Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli

not available

OGYI-T-20238/02

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/07

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/01

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/03

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/09

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/08

TEVA MAGYARORSZÁG ZRT

HU

not available

69.742

ES

not available

65413

INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. LABORATORIOS VIÑAS, S.A.

not available

65414

LABORATORIOS VIÑAS, S.A.

ES

AT/H/0293/001

1-24652

PELPHARMA HANDELS GMBH

AT

AT/H/0293/002

1-24653

PELPHARMA HANDELS GMBH

AT

not available not available DK/H/1749/001

87229/7-12-2009 87230/7-12-2009 039964010

PHARMATHEN S.A. PHARMATHEN S.A. DIFA COOPER S.P.A.

GR GR IT

DK/H/1749/001

039964022

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964034

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964046

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964059

DIFA COOPER S.P.A.

IT

List of nationally authorised medicinal products EMA/574447/2017

ES

Page 21/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoin 10mg Capsules Isotretinoin 20mg Capsules REDUCAR 10mg μαλακό καψάκιο REDUCAR 20mg μαλακό καψάκιο Dercutane 40 mg cápsulas blandas Ciscutan 30 mg – Kapseln PROCUTA 5 mg, capsule molle PROCUTA 5 mg, capsule molle PROCUTA 5 mg, capsule molle PROCUTA 5 mg, capsule molle PROCUTA 5 mg, capsule molle PROCUTA 10 mg, capsule molle

DK/H/1749/001

039964061

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964073

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964085

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964097

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964109

DIFA COOPER S.P.A.

IT

not available

PL 14894/0161

RANBAXY UK LTD

UK

not available

PL 14894/0162

RANBAXY UK LTD

UK

not available

41918/14-6-2013

GAP S.A.

GR

not available

39324/14-6-2013

GAP S.A.

GR

not available

67.878

ES

not available

135651

INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. PELPHARMA HANDELS GMBH

not available

34009 358 110 9 7

FR

not available

34009 357 840 3 2

not available

34009 358 111 5 8

not available

34009 358 112 1 9

not available

34009 357 842 6 1

not available

34009 358 107 8 6

LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE

List of nationally authorised medicinal products EMA/574447/2017

AT

FR FR FR FR FR

Page 22/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised FR

number PROCUTA 10 mg, capsule molle PROCUTA 10 mg, capsule molle PROCUTA 10 mg, capsule molle PROCUTA 10 mg, capsule molle PROCUTA 20 mg, capsule molle PROCUTA 20 mg, capsule molle PROCUTA 20 mg, capsule molle PROCUTA 20 mg, capsule molle PROCUTA 20 mg, capsule molle PROCUTA 40 mg, capsule molle Isotretinoína Mer 20 Cápsulas moles Isotretinoína Mer 20 Cápsulas moles Isotretinoína Mer 20 Cápsulas moles Isotretinoína Mer 10 Cápsulas moles Isotretinoína Mer 10 Cápsulas moles Isotretinoína Mer 10 Cápsulas moles

not available

34009 357 838 9 9

not available

34009 358 108 4 7

not available

34009 358 109 0 8

not available

34009 357 839 5 0

not available

34009 358 104 9 6

not available

34009 357 836 6 0

not available

34009 358 105 5 7

not available

34009 358 106 1 8

not available

34009 357 837 2 1

not available

34009 367 880 8 4

mg

not available

5678198

LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE LABORATOIRES EXPANSCIENCE AXONE, LDA.

mg

not available

5678297

AXONE, LDA.

PT

mg

not available

5678396

AXONE, LDA.

PT

mg

not available

5677893

AXONE, LDA.

PT

mg

not available

5677992

AXONE, LDA.

PT

mg

not available

5678099

AXONE, LDA.

PT

List of nationally authorised medicinal products EMA/574447/2017

FR FR FR FR FR FR FR FR FR PT

Page 23/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised ES

number FLEXRESAN 10 mg cápsulas blandas

not available

66.160

FLEXRESAN 20 mg cápsulas blandas

not available

66.159

ISOTROIN® 10mg καψάκια μαλακά ISOTROIN® 20mg καψάκια μαλακά ISOTROIN® 40mg καψάκια μαλακά ISOTROIN® 10mg καψάκια μαλακά ISOTROIN® 20mg καψάκια μαλακά ISOTROIN® 40mg καψάκια μαλακά Rizuderm 5mg Capsules

not available

76447/10-11-11

ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A IASIS PHARMA

not available

76449/10-11-11

IASIS PHARMA

GR

not available

78135/10-11-11

IASIS PHARMA

GR

not available

20695

IASIS PHARMA

CY

not available

20693

IASIS PHARMA

CY

not available

S00714

IASIS PHARMA

CY

not available

PL 16853/0132

UK

Isotretinoin 20mg Capsules Isotretinoin 5mg Capsules Rizuderm 20mg Capsules

not available

PL 16853/0133

not available

PL 16853/0132

not available

PL 16853/0133

Accuran, 10 mg/cap, καψάκιο, μαλακό Accuran, 20 mg/cap, καψάκιο, μαλακό ACNOGEN/GENEPHARM ACNOGEN/GENEPHARM Ciscutan 5 mg – Kapseln

not available

18066/21-03-2012

ALLIANCE PHARMACEUTICALS LTD ALLIANCE PHARMACEUTICALS LTD ALLIANCE PHARMACEUTICALS LTD ALLIANCE PHARMACEUTICALS LTD NEXUS MEDICALS S.A.

not available

18066/21-03-2012

NEXUS MEDICALS S.A.

GR

not available not available not available

38591/10/18-04-2011 38594/10/18-04-2011 1-29997

GENEPHARM S.A. GENEPHARM S.A. PELPHARMA HANDELS GMBH

GR GR AT

List of nationally authorised medicinal products EMA/574447/2017

ES GR

UK UK UK GR

Page 24/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoïne 10 PCH, capsules 10 mg Axotret10 mg, kapsułki, miękkie Axotret 20 mg, kapsułki, miękkie Isotretinoin ratiopharm 20 mg mjúk hylki Isotretinoin ratiopharm 20 mg kapsel, mjuk Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoin „ratiopharm“ 20 mg – Kapseln Isotretinoin-ratiopharm® 20 mg Weichkapseln

NL/H/902/001

RVG 27575

PHARMACHEMIE B.V

NL

not available

11318

AXXON SP. Z O.O.

PL

not available

11319

AXXON SP. Z O.O.

PL

DK/H/0298/002

IS/1/14/036/01

RATIOPHARM GMBH

IS

DK/H/0298/001

17152

RATIOPHARM GMBH

FI

DK/H/0298/001

036083018

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083020

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083032

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083044

DIFA COOPER S.P.A.

IT

DK/H/0298/001-002

036083057/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083069/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083071/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083083/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083095/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083107/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

1-24649

AT

DK/H/0298/002

54096.01.00

RATIOPHARM ARZNEIMITTEL VERTRIEBS-GMBH RATIOPHARM GMBH

List of nationally authorised medicinal products EMA/574447/2017

DE

Page 25/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Isotretinoin-ratiopharm® 10 mg Weichkapseln Isotretinoin „ratiopharm“ 10 mg – Kapseln Isotretinoin ratiopharm 20 mg kapseli, pehmeä Isotretinoin ”ratiopharm”, bløde kapsler Isotretinoin ”ratiopharm”, bløde kapsler Pharmiso Isotret-Hexal 20 mg Kapseln Isotret-HEXAL 10 mg Kapseln ISOTRETINOÏNE SANDOZ 20 MG, CAPSULES ISOTRETINOÏNE SANDOZ 10 MG, CAPSULES Accutin, kapsler, bløde Accutin, kapsler, bløde Pharmiso Isotretinoïne Sandoz 20 mg zachte capsules Isotretinoin 10 mg Capsules Isotretinoin 20 mg Capsules ISOTRETINOIN ”ORION”, BLØDE KAPSLER

DK/H/0298/001

54096.00.00

RATIOPHARM GMBH

DE

DK/H/0298/001

1-24648

AT

DK/H/0298/001

17152

RATIOPHARM ARZNEIMITTEL VERTRIEBS-GMBH RATIOPHARM GMBH

DK/H/0298/001

31473

RATIOPHARM GMBH

DK

DK/H/0298/002

31474

RATIOPHARM GMBH

DK

DK/H/0300/002 DK/H/0300/002

31478 54100.01.00

HEXAL AG HEXAL AG

DK DE

DK/H/0300/001

54100.00.00

HEXAL AG

DE

NL/H/0593/002

RVG 26548

SANDOZ B.V.

NL

NL/H/0593/001

RVG 26547

SANDOZ B.V.

NL

not available not available DK/H/0300/001 NL/H/0593/002

31531 31532 31477 BE291137

SANDOZ A/S SANDOZ A/S HEXAL AG SANDOZ N.V.

DK DK DK BE

NL/H/0593/001

PL 04416/1032

SANDOZ LTD

UK

NL/H/0593/002

PL 04416/1033

SANDOZ LTD

UK

DK/H/0889/001

34932

PHARMATHEN S.A.

DK

List of nationally authorised medicinal products EMA/574447/2017

FI

Page 26/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number ISOTRETINOIN ”ORION”, BLØDE KAPSLER Isotretinoin Orion 20 mg kapseli, pehmeä Decutan 10mg Soft Capsules Decutan 20 mg Soft Capsules

DK/H/0889/002

34933

PHARMATHEN S.A.

DK

DK/H/0889/002

21907

PHARMATHEN S.A.

FI

not available

MA155/00501

ACTAVIS GROUP HF.

MT

not available

MA155/00502

ACTAVIS GROUP HF.

MT

List of nationally authorised medicinal products EMA/574447/2017

Page 27/27

Isotretinoin (oral formulations) - European Medicines Agency - Europa ...

Jul 19, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

340KB Sizes 7 Downloads 259 Views

Recommend Documents

Isotretinoin - European Medicines Agency - Europa EU
Nov 30, 2017 - List of nationally authorised medicinal products. EMA/787886/2017. Page 5/30. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the ..... 18066/21-03-2012. NEXUS ME

triamcinolone (intraocular formulations) - European Medicines Agency
Oct 26, 2017 - Authorisation number. National Authorisation Number. MAH of product in the member state. Member State where product is authorised. TRIESENCE 40 mg/ml, sospensione iniettabile. DE/H/2294/001. 042015014. ALCON ITALIA S.P.A.. IT. Triesenc

ketorolac (ophtalmic formulations) - European Medicines Agency
Mar 8, 2018 - National Authorisation Number. MAH of product in the member state. Member State where product is authorised. ACULAR 0,5 POUR CENT, collyre not available. NL 16248. ALLERGAN FRANCE. FR. ACULAR 0,5%. Augentropfen. IE/H/0101/001. 1-21783.

isotretinoin (oral formulations): CMDH scientific conclusions and ...
Sep 2, 2017 - Summary of Product Characteristics. •. Section 4.8. The following adverse reactions should be added under the SOC “Reproductive system and ...

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

drospirenone / ethinylestradiol - European Medicines Agency - Europa ...
May 5, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för